Identification of AMP-activated protein kinase targets by a consensus sequence search of the proteome
- Traci L Marin†1, 5,
- Brendan Gongol†1, 5,
- Marcy Martin1, 2,
- Stephanie J King1,
- Lemar Smith1,
- David A Johnson1,
- Shankar Subramaniam3,
- Shu Chien3, 4 and
- John Y-J Shyy1, 2Email author
© Marin et al.; licensee BioMed Central. 2015
Received: 20 August 2014
Accepted: 24 February 2015
Published: 11 March 2015
AMP-activated protein kinase (AMPK) is a heterotrimeric serine/threonine protein kinase that is activated by cellular perturbations associated with ATP depletion or stress. While AMPK modulates the activity of a variety of targets containing a specific phosphorylation consensus sequence, the number of AMPK targets and their influence over cellular processes is currently thought to be limited.
We queried the human and the mouse proteomes for proteins containing AMPK phosphorylation consensus sequences. Integration of this database into Gaggle software facilitated the construction of probable AMPK-regulated networks based on known and predicted molecular associations. In vitro kinase assays were conducted for preliminary validation of 12 novel AMPK targets across a variety of cellular functional categories, including transcription, translation, cell migration, protein transport, and energy homeostasis. Following initial validation, pathways that include NAD synthetase 1 (NADSYN1) and protein kinase B (AKT2) were hypothesized and experimentally tested to provide a mechanistic basis for AMPK regulation of cell migration and maintenance of cellular NAD+ concentrations during catabolic processes.
This study delineates an approach that encompasses both in silico procedures and in vitro experiments to produce testable hypotheses for AMPK regulation of cellular processes.
Maintenance of cellular health requires the orchestration of multiple metabolic pathways and signaling cascades whose effects sum to maintain cellular homeostasis. AMP-activated protein kinase (AMPK) has emerged as a major regulator of cellular metabolism through activation of signaling cascades that are protective against stress. AMPK is composed of three subunits (α, β, and γ), and its activation occurs via AMP-dependent and -independent mechanisms leading to phosphorylation of the α subunit at Thr172. While elevation of the AMP: ATP ratio promotes AMP binding to the γ subunit, which permits activation by LKB1, Ca2+ influx elicits activation by CaMKKβ independent of the AMP: ATP ratio [1-3]. In addition to Thr172 phosphorylation a variety of posttranslational modifications including phosphorylation at sites other than Thr172 as well as myristolation of the β subunit can control AMPK activation .
Once activated, AMPK initiates an array of signaling cascades by phosphorylating proteins with a βϕβXXXS/TXXXϕ consensus sequence (hydrophobic, φ = M, L, I, F, or V; basic, β = R, K, or H, X = any amino acid, S/T = phosphorylation site) [5,6]. AMPK targets often contain slight variants of this consensus sequence, because AMPK can phosphorylate sites flanked by amino acid sequences lacking the basic residues in the −4/-6 positions. Additionally, the −5 hydrophobic residue may be shifted to the −4 position . Understanding how AMPK exerts its protective effects via various signaling pathways requires knowledge of all of AMPK targets, which may be more extensive than currently recognized. To explore this possibility, we mapped its phosphorylation consensus sequence to both human and mouse proteomes. Delineation of AMPK networks involved integration of these data into Gaggle software to organize putative targets based on function. Along with knowledge gained from an extensive literature review, networks were constructed and then used to predict pathways linking the putative targets . This approach yielded an extraordinarily large group of putative AMPK targets and suggested several novel pathways. The predicted pathways from this approach have the potential to redefine the role of AMPK as a survival master switch responding to stress imposed on the cell.
Results and discussion
Bioinformatics and systems biology approach
AMPK phosphorylation of NADSYN1 and transactivation through FOXO3a
AMPK activation increases cell migration through the AKT2-ATF2-MMP-2 pathway
Identification of novel AMPK substrates and signaling networks for future study
G protein coupling to the seven-transmembrane receptor (GPCRs) activity
Beta Arrestin 1 (ARRB1) regulates many signaling cascades through steric hindrance of GPCRs and serves as a scaffold for several AMPK regulated signaling molecules, including extracellular-signal-regulated kinases 1/2 (ERK1/2) and nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) [18,19]. Additionally, it participates in transactivation of c-fos and p27 by recruiting histone acetyltransferases, such as p300, which correlates with conditions that activate AMPK [20-22]. Thus, AMPK’s regulation of these signaling pathways could be mediated through ARRB1 phosphorylation (Additional file 2: Figure S1A).
5’-terminal oligopyrimidine (TOP) regulation
DDX56, also known as nucleolar helicase of 61 kDa (NOH61), is a putative RNA helicase implicated in a number of cellular processes involving alteration of RNA secondary structure . DDX56 is a constituent of free nucleoplasmic 65S preribosomal particles and seems to be necessary for ribosome synthesis at the level of large (60S) ribosomal subunit assembly . Transcriptional inhibitors, such as actinomycin D, cause complete dissociation of DDX56 from nucleolar components . All vertebrate genes encoding for the ribosomal proteins contain TOP . Interestingly, exercise-activated AMPK is accompanied by decreased translation of TOP containing genes . Although the mechanism by which activated AMPK represses the translation of ribosomal proteins is unclear, it would be independent of ribosomal protein S6 kinase or ribosomal protein S6 (rpS6) phosphorylation, both of which are known to regulate translation . One possibility is that AMPK decreases the translation of TOP genes through phosphorylation of DDX56 and in turn attenuates the functions related to TOP genes in the nucleolus (Additional file 2: Figure S1B).
Endoplasmic reticulum (ER) stress and calcium homeostasis
Calnexin (CALNX) is a type I integral ER transmembrane chaperone that transiently binds to the newly synthesized glycoproteins to assist in their folding and transport . Because ER stress is hallmarked by elevated levels of unfolded organelle proteins , CALNX has been suggested to be a key protective component of the unfolded protein response (UPR)/ER stress response, which activates protein folding/transport chaperones, while decreasing protein synthesis . Through phosphorylation of its cytoplasmic domain, CALNX also regulates sarco/endoplasmic reticulum calcium ATPase (SERCA) 2b, regulating Ca2+ signaling and Ca2+-sensitive chaperone functions in the ER . This phosphorylation event prevents the inhibition of SERCA and the subsequent Ca2+ efflux to cause ER stress . Although AMPK decreases SERCA oxidation, maintaining its activity and intracellular Ca2+ homeostasis , the mechanism for this is unknown. Our analyses suggest that AMPK regulation of Ca2+ and SERCA activity could be through phosphorylation of CALNX Ser-247 and/or Thr-93, functioning as a protective mechanism (Additional file 2: Figure S1C).
Insulin signaling and glucose transport
High-mobility group AT-hook 1 (HMGA) is a transcriptional regulator that preferentially binds to the minor groove of A/T-rich regions in double-stranded DNA to form transcriptionally active multiprotein-DNA complexes that regulate the expression of target genes such as the insulin receptor (IR) . HMGA1, through AMPK-caveolin-1 (Cav-1) signaling, can also potentiate the recruitment of transcriptional complexes to the solute carrier family 2 and glucose transporter member 3 (SLC2A3/Glut3) promoters . Importantly, Cav-1 expression is necessary for metformin induction of AMP binding and activation of AMPK . These observations suggest that the Cav-1/AMPK/HMGA1 signaling pathway is involved in the transcriptional regulation of genes important for insulin signaling and glucose transport (Additional file 2: Figure S1D).
Smooth muscle cell (SMC) recruitment and vasculogenesis
Krüppel-like Factor 2 (KLF2) is a transcription factor that regulates diverse biological processes by direct DNA binding or association with transcription co-regulators such as acetyltranferases, cAMP response element binding protein (CREBP), and p300 [35-37]. KLF2 is highly expressed in ECs during embryonic development . Klf2 genetic knockout results in defective recruitment of pericytes and vascular SMCs, impaired vasculogenesis, and lethality . The mechanism by which KLF2 recruits SMCs is poorly understood. Lysophosphatidic acid (LPA) and its receptor, LPA4, are mediators of SMC recruitment in vasculogenesis. Interestingly, the LPA4 promoter contains a KLF2 binding site . Given that AMPK activation promotes KLF2 expression , AMPK may modulate KLF2 transcriptional activity to increase LPA4 expression (Additional file 2: Figure S1E). Our analysis suggests that AMPK phosphorylation of KLF2 might provide an additional mode of regulation such as enhanced protein stability, altered protein-protein/protein-nucleic acid interactions, or increased transcriptional specificity.
Treacle, commonly referred to as TCOF, is a nucleolar protein involved in ribosomal gene transcription. TCOF interacts with upstream binding factor (UBF) and promoter selectivity factor SL1 to promote RNA polymerase I activity [42,43]. TCOF deficiency results in poor neural crest formation and proliferation due to neuroepithelial apoptosis as a consequence of decreased expression of 28s ribosomal subunit of rRNA, which ultimately results in the expression of genes important for structural development . Although the role of AMPK in regulating protein synthesis is generally believed to be negative, AMPKα1 and α2 null embryos are lethal ~10.5 days post-conception because of poor expression of genes important for growth and survival . If AMPK indeed regulates TCOF expression, it may prevent aberrant protein synthesis allowing normal embryonic development (Additional file 2: Figure S1F).
Charged multivesicular body protein 1B (CHMP1b) also plays a role in gene regulation through chromatin structural maintenance . CHMP1b associates with nuclease-resistant, condensed chromatin and the polycomb-group (PcG) proteins, which are required for maintenance of gene silencing during development. CHMP1b induction causes cell-cycle arrest and increased S-phase cell number . However, CHMP1b also forms a shell around chromatin that frequently is associated with histone H3 phosphorylation and acetylation regulating transcriptional activity [47,48]. The phosphorylation of CHMP1b by AMPK could play a role in the transition of active and inactive chromatin domains and therefore determination of heritable epigenetic marks (Additional file 2: Figure S1G).
mRNA processing and translation
Cleavage and polyadenylation specificity factor 2 (CPSF2) is the 100-kDa subunit of the CPSF that recognizes the AAUAAA consensus sequence and interacts with proteins such as the poly (A) polymerase to prompt cleavage of template mRNA and initiation of poly (A) addition in pre-mRNA 3'-end formation . This process inhibits mature mRNA degradation and activates translation . Under stress, AMPK phosphorylation of CPSF2 may increase the association of CPSF2 with the CPSF complex, thus directing CPSF’s recognition of the AAUAAA sequence (Additional file 2: Figure S1H). As a result of this process, AMPK could increase the translation of genes necessary for stress resistance. Alternatively, AMPK could inhibit this process causing the degradation of genes that are involved in excessive energy expenditure.
Cell cycle and circadian rhythm
Nuclear casein kinase and cyclin-dependent kinase substrate 1 (NUCKS1) is a substrate for casein kinase and cyclin-dependent kinase (CDK) and its phosphorylation is important for cell-cycle regulation . Upon mitosis, DNA-bound NUCKS1 translocates from the nucleus to the cytoplasm . Aberrant overexpression of NUCKS1 is correlated with breast carcinomas [50,51]. Importantly, cancer is highly associated with disrupted cellular circadian rhythm, which serves to regulate positive and negative transcriptional feedback loops. Both casein kinase and CDK are key regulators of cellular circadian rhythm as is AMPK [52,53]. Thus, AMPK could regulate circadian rhythm through phosphorylation of NUCKS1 (Additional file 2: Figure S1I).
Chromatin structure and protein folding
Zuotin-related factor 1 (ZRF1) executes both cytosolic and nuclear functions. In the nucleus, ZRF1 binds to the DNA sequence: 5’-GTCAAGC-3’ and facilitates histone 2A K119 ubiquitination leading to chromatin remodeling and transcription activation . In the cytoplasm, ZRF1, by stimulation of the ATPase activity of heat shock 70 kDa protein A14 (HSPA14) chaperones, acts as a molecular chaperone to promote protein folding of the nascent polypeptide chain as it exits the ribosome [55,56]. The phosphorylation of ZRF1 by AMPK may result in dissociation of ZRF1 from the ribosome leading to its nuclear accumulation (Additional file 2: Figure S1J). Thus, this pathway putatively regulated by AMPK would participate in epigenetic remodeling of promoters of target genes.
Conclusion and perspective
AMPK has emerged as a master regulator of metabolism by serving as an energy sensor. However, the multiple modes of AMPK activation, many of which remain elusive, indicate that AMPK’s function may extend beyond a mere energy sensor. Here, our in silico database together with biological validations suggests that AMPK is a master regulator of a broader range of cellular processes at more levels than previously recognized. Identifying AMPK targets by phosphorylation consensus sequence mapping is a simplification of the biochemistry that occurs at the substrate-enzyme interface because tertiary structure and binding domain chemistry is important for kinase substrate specificity and accessibility. However, arguably, the constraints of the active site require a minimum signature sequence within the catalytic pocket that mirrors a chemical signature flanking the phosphorylation site for catalysis to occur . Although in silico screening of the phosphorylation consensus sequence for candidate substrates of a kinase is a useful tool, the presence of such a phosphorylation consensus sequence in a given protein does not necessitate its phosphorylation in the cell. Further, some predicted AMPK targets offer slight variation to the exact consensus sequence, which presents a limitation of in silico analysis. Clearly, additional validation of individual targets and networks is necessary. Several biochemical tools are available and essential for such validation including in vitro kinase assays using recombinant protein substrates and phospho-antibodies for cellular and in vivo studies. Additional levels of AMPK phosphorylation specificity can be achieved with AMPK α1 and α2 knockout MEF cells and conditional knockout mice following treatment with AMPK agonists/activators such as exercise, caloric restriction, metformin, and AICAR. This database provides investigators with an AMPK-related network development tool that should stimulate experimental validation and offers new insights into AMPK involvement in health and disease.
Using an R script, the AMPK phosphorylation consensus sequence, βϕβXXXS/TXXXϕ (where hydrophobic, φ = M, L, I, F, or V; basic, β = R, K, or H, X = any amino acid, S/T = phosphorylation site) was mapped to human and mouse proteomes imported from ENSEMBL proteome database [5-7]. To find the proteins containing an AMPK phosphorylation consensus sequence, each peptide sequence obtained from the R script mapping was individually pasted into the BLAST algorithm provided by NCBI (http://www.ncbi.nlm.nih.gov/sutils/blink.cgi?mode=query). Using the less stringent consensus phosphorylation sequence, in which φ and β were not specified to be a specific amino acid, a Scansite search was also performed to compare with the ENSEMBL search to the SWISS-PROT protein database [5-7]. The generated databases were integrated into Gaggle software to predict and display pathways involving AMPK .
AMPK kinase assays were performed using full-length recombinant proteins in 50 mM HEPES (pH 7.4), 1 mM AMP, 1 mM (γ-32P) ATP, 5 mM MgCl2, 1 pM AMPK (Sigma Aldrich), and the putative target recombinant protein (1 nM) in a 50 μl reaction volume at 37°C for 1 h. Proteins were then resolved by using SDS-PAGE, stained with Coomassie blue, and subjected to autoradiographic analysis. Peptide assays were performed under the same conditions but with 3 nM peptide, (γ-32P) ATP 1 mM, and 1 pM AMPK. SAMS peptide (3 nM) was used as positive control. Peptide reactions were terminated by blotting samples onto Whatman grade P81 ion-exchange chromatography paper, rinsed in 1% phosphoric acid, washed in acetone, and allowed to air dry prior to submersion in 1 ml scintillation fluid. The radioactivity was measured with a Beckman LS 6500 scintillation counter.
MEF cells were isolated from mice according to standard protocols . HUVEC and C2C12 cells were purchased from American Type Culture Collection (ATCC) Cat# CRL-1730 and CRL-1772 respectively.
siRNA knockdown of gene expression
siRNA knockdown was conducted according to standard protocols. The following human siRNA sequences were used from Qiagen: Scrambled, AMPK, AKT2, and ATF2, Cat# 1022076, SI00086359, SI00305872, SI00305872 respectively. The following mouse siRNA sequences were used from Qiagen: AMPK, FOXO3a, and NADSYN1, cat# SI01388219, SI01005207, and GS78914 respectively.
Chromatin immunoprecipitation (ChIP) assay
Cells were incubated in 0.75% paraformaldehyde and harvested in FA lysis buffer (50 mM HEPES-KOH, pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS and Halt Protease inhibitors) prior to sonication with a Bioruptor 200. Protein was immunoprecipitated overnight at 4°C, washed with wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, pH 8.0, 150 mM NaCl, 20 mM Tris–HCl (pH 8.0) and eluted with 100 μl elution buffer (1% SDS, 100 mM NaHCO3). DNA was purified using Qiagen PCR purification kit prior to qPCR analysis. The following primers were used for qPCR analysis of immunoprecipitated DNA: NADSYN1 promoter forward, ATTCCTTGGCTTCCTACTGC; NADSYN1 promoter reverse, GTGTCTTGATAGATGGGCTACAG; MMP-2 promoter forward, GCAGAAGGAAAGAGGTAAGGAAG; MMP-2 promoter reverse, GAAGGAATGGTCAGAAACAGATG.
Quantitative real-time PCR (qRT-PCR)
RNA was purified using TRIzol reagent from Life Technologies. Two ng of RNA was converted to cDNA using Promega reverse transcriptase according to the manufacturer’s instructions. cDNA was then quantified via qPCR using SYBER green qPCR master mix from Bio-Rad. Results were calculated using the delta-delta ct method. The following primers were used for qRT-PCR analysis: NADSYN1 forward, GAGAGCCTTTGTCCAGTTTTG; NADSYN1 reverse, GTTGTCATCTTGTGCCTGTTC. MMP-2 forward, TTGAGAAGGATGGCAAGTACG; MMP-2 reverse, TGGTGTAGGTGTAAATGGGTG.
Cells were lysed in 10 mM Tris (pH 7.4), 0.1 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM NaF, 20 mM Na4P2O7, 2 mM sodium orthovanadate (Na3VO4), 0.1% SDS, 0.5% Sodium Deoxycholate, 1% Triton X-100, 10% Glycerol, 1 mM PMSF and protease inhibitors. The obtained cell lysates were then resolved by 10% SDS-PAGE, blocked with 5% milk, rinsed with TBST, probed with NADSYN, FOXO3a, β-actin, AMPK, MMP2, ATF2 primary antibodies from ABcam cat# ab139561, ab12162, ab8227, ab110036, ab86607, and ab47476 respectively, P-FOXO3a and P-ATF2 primary antibodies from Cell Signaling (Cat # 8174 and 9221), and secondary antibodies (Cat# 7074S and 7076S). The blotted proteins bands were made detectable by Emerson chemiluminescence substrate (ECL) and image captured on HyBlot CL autoradiography film.
MMP-2 activity was determined using Amersham Matrix Metalloproteinase-2 (MMP-2) Biotrak Activity Assay System RPN2631 protocol.
The cellular concentration of NAD+ was measured in C2C12 cell lysates using EnzyChromTM NAD+/NADH Assay Kit (E2ND-100) and protocol from BioAssay Systems.
Data are expressed as means ± SEM of at least three independent experiments. Comparisons of mean values between two groups were evaluated using a two-tailed Student’s t-test, Wilcoxon signed-rank test or Mann–Whitney U test. Unless otherwise indicated, *p < 0.05 was considered statistically significant.
This work was supported in part by National Institutes of Health Grants HL89940 (JS), HL108735 (SC, SS, JS). The authors would like to acknowledge Dr. Salvador Soriano and Mr. Brian Woo for their intellectual opinions regarding this project; Ms. Whitney Marin for optimization of the NAD+ assay; Mrs. Laura Angelica Hernandez de la Ramirez for data base management; and Ms. Sandra Cegielski and Dr. Salvador Soriano for taking the time to read and edit this manuscript.
- Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005;1:15–25.View ArticlePubMedGoogle Scholar
- Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13:251–62.View ArticlePubMedGoogle Scholar
- Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, et al. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005;2:21–33.View ArticlePubMedGoogle Scholar
- Sanz P1, Rubio T, Garcia-Gimeno MA. AMPK beta subunits: more than just a scaffold in the formation of AMPK complex. FEBS J. 2013;280:3723–33.View ArticlePubMedGoogle Scholar
- Towler MC, Hardie DG. AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling. Circ Res. 2007;100:328–41.View ArticlePubMedGoogle Scholar
- Leff T. AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. Biochem Soc Trans. 2003;31:224–7.View ArticlePubMedGoogle Scholar
- Xu Q, Yang C, Du Y, Chen Y, Liu H, Deng M, et al. AMPK regulates histone H2B O-GlcNAcylation. Nucleic Acids Res. 2014;42:5594–604.View ArticlePubMed CentralPubMedGoogle Scholar
- Shannon PT, Reiss DJ, Bonneau R, Baliga NS. The Gaggle: an open-source software system for integrating bioinformatics software and data sources. BMC Bioinformatics. 2006;7:176.View ArticlePubMed CentralPubMedGoogle Scholar
- Cantó C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 2009;458(7241):1056–60.View ArticlePubMed CentralPubMedGoogle Scholar
- LaRonde-LeBlanc N, Resto M, Gerratana B. Regulation of active site coupling in glutamine-dependent NAD (+) synthetase. Nat Struct Mol Biol. 2009;16(4):421–9.View ArticlePubMedGoogle Scholar
- Greer EL, Oskoui PR, Banko MR, Maniar JM, Gygi MP, Gygi SP, et al. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem. 2007;282(41):30107–19.View ArticlePubMedGoogle Scholar
- Nagata D, Mogi M, Walsh K. AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem. 2003;278(33):31000–6.View ArticlePubMedGoogle Scholar
- Liu Y, Tang G, Zhang Z, Wang Y, Yang GY. Metformin promotes focal angiogenesis and neurogenesis in mice following middle cerebral artery occlusion. Neurosci Lett. 2014;579C:46–51.View ArticleGoogle Scholar
- Zhu F, Zhang Y, Bode AM, Dong Z. Involvement of ERKs and mitogen- and stress-activated protein kinase in UVC-induced phosphorylation of ATF2 in JB6cells. Carcinogenesis. 2004;25(10):1847–52.View ArticlePubMedGoogle Scholar
- Fan Y, Gong Y, Ghosh PK, Graham LM, Fox PL. Spatial coordination of actin polymerization and ILK-Akt2 activity during endothelial cell migration. Dev Cell. 2009;16(5):661–74.View ArticlePubMed CentralPubMedGoogle Scholar
- Song H, Ki SH, Kim SG, Moon A. Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res. 2006;66(21):10487–96.View ArticlePubMedGoogle Scholar
- Ben-Yosef Y, Miller A, Shapiro S, Lahat N. Hypoxia of endothelial cells leads to MMP-2-dependent survival and death. Am J Physiol Cell Physiol. 2005;289(5):C1321–31.View ArticlePubMedGoogle Scholar
- Shenoy SK, Drake MT, Nelson CD, Houtz DA, Xiao K, Madabushi S, et al. Beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem. 2006;281(2):1261–73.View ArticlePubMedGoogle Scholar
- Witherow DS, Garrison TR, Miller WE, Lefkowitz RJ. Beta-arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. Proc Natl Acad Sci U S A. 2004;101(23):8603–7.View ArticlePubMed CentralPubMedGoogle Scholar
- Kang J, Shi Y, Xiang B, Qu B, Su W, Zhu M, et al. A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell. 2005;123(5):833–47.View ArticlePubMedGoogle Scholar
- DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. Beta-arrestins and cell signaling. Annu Rev Physiol. 2007;69:483–510.View ArticlePubMedGoogle Scholar
- Yu MC, Su LL, Zou L, Liu Y, Wu N, Kong L, et al. An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells. Nat Immunol. 2008;9(8):898–907.View ArticlePubMedGoogle Scholar
- Zirwes RF, Eilbracht J, Kneissel S, Schmidt-Zachmann MS. A novel helicase-type protein in the nucleolus: protein NOH61. Mol Biol Cell. 2000;11(4):1153–67.View ArticlePubMed CentralPubMedGoogle Scholar
- Avni D, Biberman Y, Meyuhas O. The 5’ terminal oligopyrimidine tract confers translational control on TOP mRNAs in a cell type- and sequence context-dependent manner. Nucleic Acids Res. 1997;25(5):995–1001.View ArticlePubMed CentralPubMedGoogle Scholar
- Reiter AK, Bolster DR, Crozier SJ, Kimball SR, Jefferson LS. AMPK represses TOP mRNA translation but not global protein synthesis in liver. Biochem Biophys Res Commun. 2008;374(2):345–50.View ArticlePubMed CentralPubMedGoogle Scholar
- Hebert DN, Molinari M. In and out of the ER: protein folding, quality control, degradation, and related human diseases. Physiol Rev. 2007;87:1377–408.View ArticlePubMedGoogle Scholar
- Coe H, Bedard K, Groenendyk J, Jung J, Michalak M. Endoplasmic reticulum stress in the absence of calnexin. Cell Stress and Chaperones. 2008;13(4):497–507.View ArticlePubMed CentralPubMedGoogle Scholar
- Zhang K, Kaufman RJ. Signaling the unfolded protein response from the endoplasmic reticulum. J Biol Chem. 2004;279(25):25935–8.View ArticlePubMedGoogle Scholar
- Roderick HL, Lechleiter JD, Camacho P. Cytosolic phosphorylation of calnexin controls intracellular Ca (2+) oscillations via an interaction with SERCA2b. J Cell Biol. 2000;149(6):1235–48.View ArticlePubMed CentralPubMedGoogle Scholar
- Cardozo AK, Ortis F, Storling J, Feng YM, Rasschaert J, Tonnesen M, et al. Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. Diabetes. 2005;54:452–61.View ArticlePubMedGoogle Scholar
- Dong Y, Zhang M, Liang B, Xie Z, Zhao Z, Asfa S, et al. Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo. Circ Res. 2010;121(6):792–803.View ArticleGoogle Scholar
- Foti D, Iuliano R, Chiefari E, Brunettii A. A nucleoprotein complex containing Sp1, C/EBPb, and HMGI-Y controls human insulin receptor gene transcription. Mol Cell Biol. 2003;23:2720–32.View ArticlePubMed CentralPubMedGoogle Scholar
- Ha TK, Chi SG. CAV1/caveolin 1 enhances aerobic glycolysis in colon cancer cells via activation of SLC2A3/GLUT3 transcription. Autophagy. 2012;8(11):1684–5.View ArticlePubMed CentralPubMedGoogle Scholar
- Salani B, Maffioli S, Hamoudane M, Parodi A, Ravera S, Passalacqua M, et al. Caveolin-1 is essential for metformin inhibitory effect on IGF1 action in non-small-cell lung cancer cells. FASEB J. 2012;26(2):788–98.View ArticlePubMedGoogle Scholar
- Anderson KP, Kern CB, Crable SC, Lingrel JB. Isolation of a gene encoding a functional zinc finger protein homologous to erythroid Krüppel-like factor: identification of a new multigene family. Mol Cell Biol. 1995;15(11):5957–65.PubMed CentralPubMedGoogle Scholar
- Evans PM, Zhang W, Chen X, Yang J, Bhakat KK, Liu C. Kruppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histoneacetylation. J Biol Chem. 2007;282(47):33994–4002.View ArticlePubMedGoogle Scholar
- Li D, Yea S, Dolios G, Martignetti JA, Narla G, Wang R, et al. Regulation of Kruppel-like factor 6 tumor suppressor activity by acetylation. Cancer Res. 2005;65(20):9216–25.View ArticlePubMedGoogle Scholar
- Kuo CT, Veselits ML, Barton KP, Lu MM, Clendenin C, Leiden JM. The KLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. Genes Dev. 1997;11(22):2996–3006.View ArticlePubMed CentralPubMedGoogle Scholar
- Wu J, Bohanan CS, Neumann JC, Lingrel JB. KLF2 transcription factor modulates blood vessel maturation through smooth muscle cell migration. J Biol Chem. 2008;283(7):3942–50.View ArticlePubMedGoogle Scholar
- Sumida H, Noguchi K, Kihara Y, Abe M, Yanagida K, Hamano F, et al. LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis. Blood. 2010;116(23):5060–70.View ArticlePubMedGoogle Scholar
- Young A, Wu W, Sun W, Benjamin Larman H, Wang N, Li YS, et al. Flow activation of AMP-activated protein kinase in vascular endothelium leads to Krüppel-like factor 2 expression. Arterioscler Thromb Vasc Biol. 2009;29(11):1902–8.View ArticlePubMed CentralPubMedGoogle Scholar
- Valdez BC, Henning D, So RB, Dixon J, Dixon MJ. The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor. Proc Natl Acad Sci U S A. 2004;101(29):10709–14.View ArticlePubMed CentralPubMedGoogle Scholar
- Poortinga G, Hannan KM, Snelling H, Walkley CR, Jenkins A, Sharkey K, et al. MAD1 and cMYC regulate UBF and rDNA transcription during granulocyte differentiation. EBMO J. 2004;23(16):3325–35.Google Scholar
- Dixon J, Jones NC, Sandell LL, Jayasinghe SM, Crane J, Rey JP, et al. Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities. Proc Natl Acad Sci U S A. 2006;103(36):13403–8.View ArticlePubMed CentralPubMedGoogle Scholar
- Viollet B, Athea Y, Mounier R, Guigas B, Zarrinpashneh E, Horman S, et al. AMPK: Lessons from transgenic and knockout animals. Front Biosci. 2009;14:19–44.View ArticleGoogle Scholar
- Howard TL, Stauffer DR, Degnin CR, Hollenberg SM. CHMP1 functions as a member of a newly defined family of vesicle trafficking proteins. J Cell Sci. 2001;114(Pt 13):2395–404.PubMedGoogle Scholar
- Stauffer DR, Howard TL, Nyun T, Hollenberg SM. CHMP1 is a novel nuclear matrix protein affecting chromatin structure and cell-cycle progression. J Cell Sci. 2001;114(Pt 13):2383–93.PubMedGoogle Scholar
- Cheung P, Tanner KG, Cheung WL, Sassone-Corsi P, Denu JM, Allis CD. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol Cell. 2000;5(6):905–15.View ArticlePubMedGoogle Scholar
- Chan S, Choi EA, Shi Y. Pre-mRNA 3’-end processing complex assembly and function. Wiley Interdiscip Rev RNA. 2011;2(3):321–35.View ArticlePubMed CentralPubMedGoogle Scholar
- Drosos Y, Kouloukoussa M, Østvold AC, Grundt K, Goutas N, Vlachodimitropoulos D, et al. NUCKS overexpression in breast cancer. Cancer Cell Int. 2009;9:19.View ArticlePubMed CentralPubMedGoogle Scholar
- Grundt K, Skjeldal L, Anthonsen HW, Skauge T, Huitfeldt HS, Østvold AC. A putative DNA-binding domain in the NUCKS protein. Arch Biochem Biophys. 2002;407(2):168–75.View ArticlePubMedGoogle Scholar
- Price JL, Blau J, Rothenfluh A, Abodeely M, Kloss B, Young MW. Double-time is a novel Drosophila clock gene that regulates PERIOD protein accumulation. Cell. 1998;94(1):83–95.View ArticlePubMedGoogle Scholar
- Um JH, Pendergast JS, Springer DA, Foretz M, Viollet B, Brown A, et al. AMPK regulates circadian rhythms in a tissue- and isoform-specific manner. PLoS One. 2011;6(3):e18450.View ArticlePubMed CentralPubMedGoogle Scholar
- Richly H, Rocha-Viegas L, Ribeiro JD, Demajo S, Gundem G, Lopez-Bigas N, et al. Transcriptional activation of polycomb-repressed genes by ZRF1. Nature. 2010;468(7327):1124–8.View ArticlePubMedGoogle Scholar
- Otto H, Conz C, Maier P, Wölfle T, Suzuki CK, Jenö P, et al. The chaperones MPP11 and Hsp70L1 form the mammalian ribosome-associated complex. Proc Natl Acad Sci U S A. 2005;102(29):10064–9.View ArticlePubMed CentralPubMedGoogle Scholar
- Hundley HA, Walter W, Bairstow S, Craig EA. Human Mpp11 J protein: ribosome- tethered molecular chaperones are ubiquitous. Science. 2005;308(5724):1032–4.View ArticlePubMedGoogle Scholar
- Johnson LN. Structural basis for substrate recognition and control in protein kinases. Ernst Schering Res Found Workshop. 2001;34:47–69.PubMedGoogle Scholar
- Xu J. Preparation, culture, and immortalization of mouse embryonic fibroblasts. Curr Protoc Mol Biol. 2005;Chapter 28(Unit 28):1.PubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.